3o23: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "3o23" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3o23. | [[Image:3o23.png|left|200px]] | ||
{{STRUCTURE_3o23| PDB=3o23 | SCENE= }} | {{STRUCTURE_3o23| PDB=3o23 | SCENE= }} | ||
===Human unphosphorylated IGF1-R Kinase domain in complex with an hydantoin inhibitor=== | ===Human unphosphorylated IGF1-R Kinase domain in complex with an hydantoin inhibitor=== | ||
{{ABSTRACT_PUBMED_21441024}} | {{ABSTRACT_PUBMED_21441024}} | ||
==About this Structure== | ==About this Structure== | ||
[[3o23]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3O23 OCA]. | [[3o23]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3O23 OCA]. | ||
==See Also== | |||
*[[Insulin-like growth factor receptor|Insulin-like growth factor receptor]] | |||
==Reference== | ==Reference== | ||
| Line 28: | Line 20: | ||
[[Category: Guilloteau, J P.]] | [[Category: Guilloteau, J P.]] | ||
[[Category: Maignan, S.]] | [[Category: Maignan, S.]] | ||
[[Category: Protein kinase]] | |||
[[Category: Transferase-transferase inhibitor complex]] | |||
Revision as of 14:51, 20 October 2012
Human unphosphorylated IGF1-R Kinase domain in complex with an hydantoin inhibitor
Template:ABSTRACT PUBMED 21441024
About this Structure
3o23 is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Lesuisse D, Mauger J, Nemecek C, Maignan S, Boiziau J, Harlow G, Hittinger A, Ruf S, Strobel H, Nair A, Ritter K, Malleron JL, Dagallier A, El-Ahmad Y, Guilloteau JP, Guizani H, Bouchard H, Venot C. Discovery of the first non-ATP competitive IGF-1R kinase inhibitors: Advantages in comparison with competitive inhibitors. Bioorg Med Chem Lett. 2011 Apr 15;21(8):2224-8. Epub 2011 Mar 4. PMID:21441024 doi:10.1016/j.bmcl.2011.03.003